| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/23/2006 | US20060063727 Tr4/tr2 response elements |
| 03/23/2006 | US20060063721 AI-2 compounds and analogs based on salmonella typhimurium LsrB structure |
| 03/23/2006 | US20060063716 Intermedin and its uses |
| 03/23/2006 | US20060063715 Multivalent antigen-binding proteins |
| 03/23/2006 | US20060063709 Nuclear factors associated with transcriptional regulation |
| 03/23/2006 | US20060063708 Administering melanocyte stimulating hormone to peripheral tissue |
| 03/23/2006 | US20060063704 Somatostatin-dopamine chimeric analogs |
| 03/23/2006 | US20060063700 Methods to stimulate insulin production by pancreatic Beta-cells |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063258 Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders |
| 03/23/2006 | US20060063250 Use of modified novirhabdoviruses to obtain vaccines |
| 03/23/2006 | US20060063244 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 03/23/2006 | US20060063243 Cloning and expression of microbial phytase |
| 03/23/2006 | US20060063236 Interleukin-4 (IL-4) mutein receptor antagonist operatively linked to an interleukin-9 (IL-9) mutein receptor antagonist; can specifically disrupt the formation of an IL-4 receptor, an IL-9 receptor, an interleukin-13 (IL-13) receptor; useful in treatment of asthma and other pulmonary disorders |
| 03/23/2006 | US20060063233 Cytokine protein family |
| 03/23/2006 | US20060063229 mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 03/23/2006 | US20060063227 Secreted proteins and polynucleotides encoding them |
| 03/23/2006 | US20060063203 Vascular endothelial cell growth factor variants and uses thereof |
| 03/23/2006 | US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/23/2006 | US20060063182 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria |
| 03/23/2006 | US20060063179 MIFL- a new partner gene of MLL and methods of use thereof |
| 03/23/2006 | US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 03/23/2006 | US20060063156 Outcome prediction and risk classification in childhood leukemia |
| 03/23/2006 | US20060063152 Novel gene and protein encoded by the gene |
| 03/23/2006 | US20060063149 Compositions and methods for detecting pathogen infection |
| 03/23/2006 | US20060063143 Immortalized hypothalamic neuronal cell lines |
| 03/23/2006 | US20060062806 Flavivirus variants having phenotypic variation and immunogenic compositions thereof |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062804 High sensitivity and specificity of the serologic detection; rapid, simple, low cost test for commercially available, large scale screening of SARS patients |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062801 Immunogens; electrical injection; electroporation |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | US20060062798 Vaccines |
| 03/23/2006 | US20060062797 Novel materials and methods for the treatment of Alzheimer's disease patients |
| 03/23/2006 | US20060062795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 03/23/2006 | US20060062792 Novel human p53 splice variant displaying differential transcriptional activity |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062788 Method for determining MIF content |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062780 Myelin oligodendrocyte glycoprotein; 1st domain: deimmunized, autoreactive antigen specifically recognized by Ig receptors of autoreactive B-cells; 2nd domain: effector molecule capable of interacting with or activating NK-cells, T-cells, macrophages, monocytes or granulocytes; autoimmune diseases |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062775 Method for the production of protamine |
| 03/23/2006 | US20060062765 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/23/2006 | US20060062761 Modified interferon alpha with reduced immunogenicity |
| 03/23/2006 | US20060062727 Compositions and methods for the diagnosis and treatment of tumor |
| 03/23/2006 | US20060060211 Modifying nicotine and nitrosamine levels in tobacco |
| 03/23/2006 | DE4007605B4 SDK-Peptide, Verfahren zu ihrer Herstellung und diese enthaltende therapeutischen Zusammensetzungen SDK peptides, process for their preparation and therapeutic compositions containing |
| 03/23/2006 | DE102004043629A1 New communication-mediating domains of biosynthesis complexes, useful for preparation of modified forms of non-ribosomal peptides or their polyketide complexes, potential therapeutic agents |
| 03/23/2006 | DE102004043153A1 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin |
| 03/23/2006 | DE102004043009A1 Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen Transport protein for introducing chemical compounds into nerve cells |
| 03/23/2006 | CA2580713A1 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 03/23/2006 | CA2580372A1 Isolation of growth and differentiating factors from colostrum |
| 03/23/2006 | CA2576940A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2006 | CA2576768A1 Method of reducing the effects of a.beta. and compositions therefore |
| 03/23/2006 | CA2576435A1 Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
| 03/23/2006 | CA2576354A1 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 03/23/2006 | CA2575803A1 Progesterone receptor structure |
| 03/22/2006 | EP1637885A1 Method of screening by using conformation sensitive peptides |
| 03/22/2006 | EP1637614A2 Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus) |
| 03/22/2006 | EP1637608A2 Recombinant adenoviral vector and methods of use |
| 03/22/2006 | EP1637607A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 03/22/2006 | EP1637606A2 Triacylglycerol lipases |
| 03/22/2006 | EP1637604A2 Method for producing proteins |
| 03/22/2006 | EP1637602A1 Recombinant method for preparing of a complete malaria antigen gp190/msp1 |
| 03/22/2006 | EP1637601A2 Proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2006 | EP1637600A1 Chromosome 1 gene and gene products related to Alzheimer's disease |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637597A1 Method of nucleic acid infusion |
| 03/22/2006 | EP1637541A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/22/2006 | EP1637540A1 Hyperactive Stat molecules and their use in assays employing gene activation |
| 03/22/2006 | EP1637166A2 Virus-like particles for the induction of autoantibodies |
| 03/22/2006 | EP1637156A1 Systemic administration of osteogenic proteins in the treatment of metabolic bone diseases |
| 03/22/2006 | EP1636594A2 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 03/22/2006 | EP1636593A1 Modulating the interaction between hgf beta chain and c-met |
| 03/22/2006 | EP1636588A2 Methods for detecting cancer and monitoring cancer progression |
| 03/22/2006 | EP1636583A2 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 03/22/2006 | EP1636383A1 Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition |
| 03/22/2006 | EP1636370A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 03/22/2006 | EP1636367A2 Method for producing a recombinant protein of interest and protein thus produced |
| 03/22/2006 | EP1636365A1 Cholesterol biosynthesis pathway modulators and uses thereof |
| 03/22/2006 | EP1636359A2 Methods for treating pain |
| 03/22/2006 | EP1636343A2 Synthetic mammalian retrotransposon gene |
| 03/22/2006 | EP1636339A2 Novel calcium channel |
| 03/22/2006 | EP1636270A2 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 03/22/2006 | EP1636269A2 Extracellular aspergillus polypeptides |
| 03/22/2006 | EP1636267A2 Modified hirudin proteins and t-cell epitopes in hirudin |
| 03/22/2006 | EP1636266A2 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof |
| 03/22/2006 | EP1636265A2 Binding molecules for the treatment of myeloid cell malignancies |
| 03/22/2006 | EP1636263A2 Pegylated soluble gp130-dimers useful as a medicament |
| 03/22/2006 | EP1636262A1 Interferon gamma-like protein |
| 03/22/2006 | EP1636261A2 Thrombopoietin proteins with improved properties |
| 03/22/2006 | EP1636260A2 Improved secretion of neublastin |
| 03/22/2006 | EP1636259A2 Chemokine-binding protein thap1, methods and use thereof |
| 03/22/2006 | EP1636258A2 Angiogenic factor and inhibitors thereof |
| 03/22/2006 | EP1636257A2 Peptides enhancing ceh activity or acat inhibitory activity, pharmaceutical compositions comrising these peptides and their use in the treatment of atherosclerosis |
| 03/22/2006 | EP1636256A2 Interferon variants with improved properties |
| 03/22/2006 | EP1636255A1 Modified oleosins |
| 03/22/2006 | EP1636254A2 Replikin peptides and uses thereof |
| 03/22/2006 | EP1636251A2 Ccn1 compositions and methods |
| 03/22/2006 | EP1636250A2 Self-assembling peptides incorporating modifications and methods of use thereof |